Key Record Dates
ClinicalTrials.gov Identifier: | NCT04830202 |
---|---|
Brief Title: | Expanded Access to Telisotuzumab Vedotin |
First Submitted : | March 31, 2021 |
First Submitted that Met QC Criteria : | March 31, 2021 |
First Posted : | April 5, 2021 |
Last Update Submitted that Met QC Criteria : | January 5, 2023 |
Last Update Posted : | January 6, 2023 |